Clinical trial
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
NCT00324012 · Rigshospitalet, Denmark, Other · Completed
Key facts
| NCT number | NCT00324012 |
|---|---|
| Title | Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma |
| Official title | Phase II Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adrenocortical Carcinoma |
| Intervention type | Drug |
| Interventions | cisplatin, taxotere |
| Enrollment | 19 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | May 10, 2006 |
| Last update posted | Feb 22, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: